Incyte Genomics Inc (INCY) Financials
Key financial figures for Incyte Genomics Inc (Q2 2026).
- Revenue
- $1.7B
- Net Income
- $586M
- EPS
- $2.92
- Total Assets
- $7.9B
- Operating Cash Flow
- $508M
Full income statement, balance sheet, and cash flow for Incyte Genomics Inc on SentiSense.